MediFind found 5 doctor with experience in Analgesic Nephropathy near Fredericksburg, VA. Of these, 5 are Experienced.
Fredericksburg Nephrology Associates Inc
Tarik Noureldeen is a Nephrologist in Fredericksburg, Virginia. Dr. Noureldeen is rated as an Experienced provider by MediFind in the treatment of Analgesic Nephropathy. His top areas of expertise are Renovascular Hypertension, Nephrosclerosis, Acute Kidney Failure, and End-Stage Renal Disease (ESRD). Dr. Noureldeen is currently accepting new patients.
Fredericksburg Nephrology Associates Inc
Robert Canady is a Nephrologist in Fredericksburg, Virginia. Dr. Canady is rated as an Experienced provider by MediFind in the treatment of Analgesic Nephropathy. His top areas of expertise are Renovascular Hypertension, Nephrosclerosis, Acute Kidney Failure, and End-Stage Renal Disease (ESRD). Dr. Canady is currently accepting new patients.
Thomas Fortune is a Nephrologist in Fredericksburg, Virginia. Dr. Fortune is rated as an Experienced provider by MediFind in the treatment of Analgesic Nephropathy. His top areas of expertise are Nephrosclerosis, End-Stage Renal Disease (ESRD), Renovascular Hypertension, and Chronic Kidney Disease. Dr. Fortune is currently accepting new patients.
Fredericksburg Nephrology Associates Inc
Lakshmi Turlapati is a Nephrologist in Fredericksburg, Virginia. Dr. Turlapati is rated as an Experienced provider by MediFind in the treatment of Analgesic Nephropathy. Her top areas of expertise are Nephrosclerosis, Acute Kidney Failure, Renovascular Hypertension, and End-Stage Renal Disease (ESRD). Dr. Turlapati is currently accepting new patients.
Fredericksburg Nephrology Associates Inc
Ankur Sandhu is a Nephrologist in Fredericksburg, Virginia. Dr. Sandhu is rated as an Experienced provider by MediFind in the treatment of Analgesic Nephropathy. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Acute Kidney Failure. Dr. Sandhu is currently accepting new patients.
Last Updated: 10/30/2025




